The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Polymer-drug conjugates: Recent development in clinical oncology
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Structure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Development of the polymer micelle carrier system for doxorubicin
Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00341-8 · Cited by 570
Drug-polymer conjugates: potential for improved chemotherapy
Duncan, R. (1992) · Anti-Cancer Drugs · doi:10.1097/00001813-199206000-00001 · Cited by 444
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Taxol (paclitaxel): mechanisms of action.
Horwitz, S. B. (1994) · PubMed · Cited by 434
Wang, Y.-S., Youngster, S., Grace, M., Bausch, J., Bordens, R., & Wyss, D. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00027-3 · Cited by 420
Poly(l-glutamic acid)–anticancer drug conjugates
Li, C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00045-5 · Cited by 414
Self-citationGreenwald, R. B. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00331-5 · Cited by 353
Li, C., Yu, D. F., Newman, R. A., Cabral, F., Stephens, L. C., Hunter, N. R., Milas, L., & Wallace, S. (1998) · PubMed · Cited by 340
Self-citationPegaspargase: a review of clinical studies
Graham, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00110-8 · Cited by 322
Mono-N-terminal poly(ethylene glycol)–protein conjugates
Kinstler, O., Molineux, G., Treuheit, M., Ladd, D., & Gegg, C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00023-6 · Cited by 306
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
Pericellular cathepsin B and malignant progression
Roshy, S., Sloane, B. F., & Moin, K. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023007717757 · Cited by 223
Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer Models
Schluep, T., Hwang, J., Cheng, J., Heidel, J. D., Bartlett, D. W., Hollister, B., & Davis, M. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1566 · Cited by 222
Minko, T., Kope?kov�, P., & Kope?ek, J. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<108::aid-ijc17>3.0.co;2-8 · Cited by 198
Polymer–drug conjugates: towards a novel approach for the treatment of endrocine-related cancer
Duncan, R., Vicent, M. J., Greco, F., & Nicholson, R. I. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01045 · Cited by 179
Seymour, L., Ulbrich, K., Steyger, P., Brereton, M., Subr, V, Strohalm, J., & Duncan, R. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.363 · Cited by 164
Synthesis and in Vivo Antitumor Activity of Poly( l -glutamic acid) Conjugates of 20(S)-Camptothecin
Bhatt, R., de Vries, P. W., Tulinsky, J., Bellamy, G., Baker, B., Singer, J. W., & Klein, P. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020022r · Cited by 152
Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane
Singer, J. W., Shaffer, S. A., Baker, B., Bernareggi, A., Stromatt, S. C., Nienstedt, D., & Besman, M. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200503000-00003 · Cited by 149
Schluep, T., Cheng, J., Khin, K. T., & Davis, M. E. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0091-7 · Cited by 142
Singer, J. W., Bhatt, R., Tulinsky, J., Buhler, K. R., Heasley, E., Klein, P., & de Vries, P. W. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00323-6 · Cited by 139
Carvalho, M. A., Marsillac, S. M., Karchin, R., Manoukian, S., Grist, S. A., Swaby, R. F., Ürményi, T. P., Rondinelli, E., Silva, R., Gayol, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3297 · Cited by 130
Tumor Priming Enhances Delivery and Efficacy of Nanomedicines
Lü, D., Wientjes, M. G., Lu, Z., & Au, J. L. ‐. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121632 · Cited by 128
Campone, M., Rademaker-Lakhai, J. M., Bennouna, J., Howell, S. B., Nowotnik, D. P., Beijnen, J. H., & Schellens, J. H. M. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0397-0 · Cited by 125
Bissett, D., Cassidy, J., Bono, J. S. D., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601922 · Cited by 125
Sabbatini, P. J., Aghajanian, C. A., Dizon, D. S., Anderson, S., Dupont, J., Brown, J. V., Peters, W. A., Jacobs, A. D., Mehdi, A., Rivkin, S. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.043 · Cited by 125
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin
Schoemaker, N. E., van Kesteren, C., Rosing, H., Jansen, S., Swart, M., Lieverst, J. A., Fraier, D., Breda, M., Pellizzoni, C., Spinelli, R., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600516 · Cited by 122
Li, C., Newman, R. A., Wu, Q.-P., Shi, K., Chen, W., Hutto, T. Y., Kan, Z., Brannan, M. D., Charnsangavej, C., & Wallace, S. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800000168 · Cited by 114
Self-citationAntitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
Li, C., Price, J. E., Milas, L., Hunter, N. R., Shi, K., Yu, D. F., Charnsangavej, C., & Wallace, S. (1999) · PubMed · Cited by 114
Self-citationBoddy, A. V., Plummer, E. R., Todd, R., Sludden, J., Griffin, M., Robson, L., Cassidy, J., Bissett, D., Bernareggi, A., Verrill, M. W., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0803 · Cited by 108
Shaffer, S. A., Baker-Lee, C., Kennedy, J., Lai, M. S., de Vries, P. W., Buhler, K. R., & Singer, J. W. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0296-4 · Cited by 104
Homsi, J., Simon, G. R., Garrett, C. R., Springett, G. M., Conti, R. C. D., Chiappori, A., Münster, P. N., Burton, M. K., Stromatt, S. C., Allievi, C., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2821 · Cited by 103
Li, C., Shi, K., Wu, Q., Tansey, W., Hunter, N. R., Buchmiller, L., Milas, L., Charnsangavej, C., & Wallace, S. (2000) · PubMed · Cited by 102
Self-citationDuncan, R., Cable, H. C., Lloyd, J. B., Rejmanová, P., & Kopec̆ek, J. (1982) · Bioscience Reports · doi:10.1007/bf01122173 · Cited by 101
DUNCAN, R., Rejmanová, P., Kopec̆ek, J., & LLOYD, J. (1981) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(81)90058-1 · Cited by 98
Drug Delivery Systems. 2. Camptothecin 20-O-Poly(ethylene glycol) Ester Transport Forms
Greenwald, R. B., Pendri, A., Conover, C., Gilbert, C. W., Yang, R., & Xia, J. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9600555 · Cited by 92
Soepenberg, O., Dumez, H., Verweij, J., de Jong, F. A., de Jonge, M. J. A., Thomas, J., Eskens, F. A. L. M., van Schaik, R. H. N., Selleslach, J., ter Steeg, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1758 · Cited by 88
Phase I and Pharmacokinetic Study of DE-310 in Patients with Advanced Solid Tumors
Soepenberg, O., de Jonge, M. J. A., Sparreboom, A., de Bruin, P. C., Eskens, F. A. L. M., de Heus, G., Wanders, J., Cheverton, P., Ducharme, M. P., & Verweij, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.703.11.2 · Cited by 75
Paclitaxel Poliglumex (PPX-Xyotax) and Concurrent Radiation for Esophageal and Gastric Cancer
DiPetrillo, T. A., Milas, L., Evans, D. L., Akerman, P., Ng, T., Miner, T., Cruff, D., Chauhan, B., Iannitti, D. A., Harrington, D. T., et al. (2006) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000224494.07907.4e · Cited by 74
Conjugation of Camptothecins to Poly‐(l‐Glutamic Acid)
Singer, J. W., de Vries, P. W., Bhatt, R., Tulinsky, J., KLEIN, P., Li, C., Milas, L., LEWIS, R. A., & Wallace, S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb07032.x · Cited by 66
Self-citationAlbain, K. S., Belani, C. P., Bonomi, P., O'Byrne, K. J., Schiller, J. H., & Socinski, M. A. (2006) · Clinical Lung Cancer · doi:10.3816/clc.2006.n.027 · Cited by 57
Posey, J. A., Saif, M. W., Carlisle, R. R., Goetz, A. D., Rizzo, J. D., Stevenson, S., Rudoltz, M. S., Kwiatek, J., Simmons, P., Rowinsky, E. K., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0783 · Cited by 52
Bonomi, P. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.415 · Cited by 46
Nemunaitis, J. J., Cunningham, C. C., Senzer, N. N., Gray, M., Oldham, F. B., Pippen, J., Mennel, R. G., & Eisenfeld, A. J. (2005) · Cancer Investigation · doi:10.1080/07357900500359935 · Cited by 41
Magnetic Resonance Imaging of Therapy-Induced Necrosis Using Gadolinium-Chelated Polyglutamic Acids
Jackson, E. F., Esparza‐Coss, E., Wen, X., Ng, C. S., Daniel, S. L., Price, R. E., Rivera, B., Charnsangavej, C., Gelovani, J. G., & Li, C. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.011 · Cited by 40
Self-citationInoue, K., Kumazawa, E., Kuga, H., Susaki, H., Masubuchi, N., & Kajimura, T. (2004) · Advances in experimental medicine and biology · doi:10.1007/0-306-47932-x_9 · Cited by 35
Multani, A. S., Li, C., Özen, M., Imam, A. S., Wallace, S., & Pathak, S. (1999) · Oncology Reports · doi:10.3892/or.6.1.39 · Cited by 35
Self-citationTechnology evaluation: PK1, Pfizer/Cancer Research UK.
Bilim, V. N. (2003) · PubMed · Cited by 30
Allouache, D., Gawande, S. R., Tubiana-Hulin, M., Tubiana-Mathieu, N., Piperno-Neumann, S., Mefti, F., Bozec, L., & Génot, J.-Y. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-151 · Cited by 27
Phase I study of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies
Springett, G. M., Takimoto, C. H. M., McNamara, M., Doroshow, J. H., Syed, S. S., Eastham, E., Spriggs, D. R., Pezzulli, S., Michelson, G. C., & Dupont, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.3127 · Cited by 24
Boddy, A., Todd, R., Verrill, M., Sludden, J., Fishwick, K., Robson, L., Cassidy, J., Bisset, D., Garzone, P., & Calvert, A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80747-x · Cited by 18
Phase I and pharmacological study of CT-2103, a poly(L-glutamic acid)-paclitaxel conjugate
Todd, R., BODDY, A., Verrill, M., Sludden, J., Griffin, M., Elliott, S., Fishwick, K., Robson, L., Cassidy, J., Main, M., et al. (2001) · UCL Discovery (University College London) · doi:10.25405/ncl.34646574 · Cited by 9
Cited by
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
“Achievements and future challenges Nanoparticles provide opportunities for designing and tuning properties that are not possible with other types of therapeutics, and as more clinical data become available (see also reviews on polymer–drug conjugate”
BackgroundPoly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Metadata
- Authors
- Li, C., & Wallace, S.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 60
- Issue
- 8
- Pages
- 886-898
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1995591348
- Cited by
- 436
- References
- 57
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.